{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:01:16Z","timestamp":1761512476533},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ijrobp.2007.09.048","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T08:43:40Z","timestamp":1196498620000},"page":"132-138","source":"Crossref","is-referenced-by-count":37,"title":["HI-CHART: A Phase I\/II Study on the Feasibility of High-Dose Continuous Hyperfractionated Accelerated Radiotherapy in Patients With Inoperable Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"71","author":[{"given":"Dirk","family":"De Ruysscher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinus","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Hochstenbag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiel","family":"Geraedts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Simons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Verschueren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Minken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren M.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Lambin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2007.09.048_bib1","first-page":"2499","article-title":"Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III nsclc: RTOG 9410","author":"Curran","year":"2003","journal-title":"Proc ASCO"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib2","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0167-8140(99)00087-0","article-title":"Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multi-center trial","volume":"52","author":"Saunders","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.117.2.358","article-title":"Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group","volume":"117","author":"Sause","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib5","first-page":"82","article-title":"Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer","volume":"6","author":"Rosenzweig","year":"2000","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2001.19.1.127","article-title":"Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy update of a phase I trial","volume":"19","author":"Hayman","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.lungcan.2003.09.015","article-title":"Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer","volume":"44","author":"Narayan","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib8","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1200\/JCO.2004.03.022","article-title":"Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: A dose-escalation phase I trial","volume":"22","author":"Socinski","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0360-3016(02)02958-9","article-title":"High-dose conformal radiotherapy for treatment of stage IIIA\/IIIB non-small-cell lung cancer: Technical issues and results of a phase I\/II trial","volume":"54","author":"Rosenman","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2005.02.010","article-title":"High-dose radiation improved local tumor control and overall survival in patients with inoperable\/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study","volume":"63","author":"Kong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijrobp.2004.06.260","article-title":"Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma","volume":"61","author":"Bradley","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.radonc.2003.09.006","article-title":"Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy","volume":"71","author":"Thirion","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2006.04.034","article-title":"Final results of a Phase I\/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy","volume":"66","author":"Belderbos","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib14","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/bjc.1998.678","article-title":"Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy week end less) in non-small cell lung cancer","volume":"78","author":"Saunders","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/clon.2002.0121","article-title":"Dose-escalation with CHARTWEL (continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment of locally advanced non-small cell lung cancer","volume":"14","author":"Saunders","year":"2002","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.22123","article-title":"Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer","volume":"107","author":"Rojas","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1053\/clon.2002.0117","article-title":"From CHART to CHARTWEL in non-small cell lung cancer: Clinical radiobiological modelling of the expected change in outcome","volume":"14","author":"Bentzen","year":"2002","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ijrobp.2004.12.019","article-title":"Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study","volume":"62","author":"De Ruysscher","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s002590050327","article-title":"FDG-PET scan in potentially operable non-small cell lung cancer: Do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?","volume":"25","author":"Vansteenkiste","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib20","series-title":"International Commission on Radiation Units and Measurements. ICRU report 50. Prescribing, recording, and reporting photon beam therapy","year":"1993"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0360-3016(92)90964-J","article-title":"Spinal cord radiation tolerance","volume":"30","author":"Schultheiss","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00019052-199812000-00003","article-title":"Radiation myelopathy","volume":"11","author":"Rampling","year":"1998","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijrobp.2004.05.029","article-title":"Dose-volume effects in rat thoracolumbar spinal cord: An evaluation of NTCP models","volume":"60","author":"Philippens","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0167-8140(99)00151-6","article-title":"Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer","volume":"53","author":"Bentzen","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.radonc.2007.03.003","article-title":"Routine individualised patient dosimetry using electronic portal imaging devices","volume":"83","author":"Nijsten","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib27","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/0169-5002(94)91859-7","article-title":"Endpoints for multi-modal clinical trials in stage III non-small cell lung cancer (NSCLC): A consensus report","volume":"11","author":"Green","year":"1994","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib28","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/0360-3016(88)90164-2","article-title":"International clinical trials in radiation oncology: The late effects of toxicity scoring","volume":"114","author":"Rubin","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib29","series-title":"Basic clinical radiobiology","first-page":"134","article-title":"The linear-quadratic model in clinical practice","author":"Bentzen","year":"2002"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0360-3016(01)01823-5","article-title":"Dose, volume, and tumor control prediction in primary radiotherapy of nonsmall-cell lung cancer","volume":"52","author":"Willner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0360-3016(00)01374-2","article-title":"A new approach to dose escalation in non-small-cell lung cancer","volume":"49","author":"Mehta","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.lungcan.2005.11.007","article-title":"Radiation-induced narrowing of the tracheobronchial tree: An in-depth analysis","volume":"52","author":"Kelsey","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/JCO.2006.09.7469","article-title":"Stereotactic body radiation therapy in multiple organ sites","volume":"25","author":"Timmerman","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib34","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ijrobp.2006.05.022","article-title":"Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: A prospective clinical study","volume":"66","author":"Bosmans","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.048_bib35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijrobp.2005.01.032","article-title":"Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: An analysis of 4DCT datasets","volume":"62","author":"Underberg","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301607043799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301607043799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T13:26:22Z","timestamp":1546435582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301607043799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0360301607043799"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2007.09.048","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}